Rep. Scott Peters on the Pill Penalty, PBMs, China & America’s Biotech Future
China and biotech competition. Drug pricing reform. The FDA. PBMs. America’s innovation economy.
This week on the Making Medicine Podcast, John Stanford sits down with Rep. Scott Peters to discuss the future of American biotech innovation, the importance of ending the “pill penalty,” and why China’s rapid rise in biotechnology is becoming a major strategic concern for the United States.
Representing one of the country’s leading biotech hubs in San Diego, Congressman Peters explains why policies tied to the Inflation Reduction Act and investment incentives directly impact whether innovative…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.